Streptokinase A

Description:

Description
  • Accession: P10520
  • Swissprot: STRP_STRP1
  • Organism: Streptococcus pyogenes serotype M1
  • Gene: ska
  • Target class: Enzyme

Drug Relations:

cefaclor
Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN. Bioactivity details MOA
cefixime
A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases. Bioactivity details MOA
cefoxitin
A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Bioactivity details MOA
chloramphenicol
An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Bioactivity details MOA
dicloxacillin
One of the PENICILLINS which is resistant to PENICILLINASE. Bioactivity details MOA
meropenem
an antibacterial drug readily penetrates the cell wall of most Gram-positive and Gram-negative bacteria to reach penicillin-binding-protein (PBP) targets, the bactericidal activity of meropenem results from the inhibition of cell wall synthesis Bioactivity details MOA
piperacillin
Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics. Bioactivity details MOA
thiamphenicol
A methylsulfonyl analog of CHLORAMPHENICOL. It is an antibiotic and immunosuppressive agent. Bioactivity details MOA